Paloma Partners’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-8,632
| Closed | -$226K | – | 1958 |
|
|
2021
Q1 | $226K | Buy |
+8,632
| New | +$226K | ﹤0.01% | 1493 |
|
|
2020
Q4 | – | Sell |
-12,679
| Closed | -$264K | – | 1918 |
|
|
2020
Q3 | $264K | Buy |
12,679
+2,309
| +22% | +$48.1K | 0.01% | 1413 |
|
|
2020
Q2 | $247K | Buy |
+10,370
| New | +$247K | ﹤0.01% | 1425 |
|
|
2019
Q1 | – | Sell |
-7,230
| Closed | -$240K | – | 1521 |
|
|
2018
Q4 | $240K | Buy |
+7,230
| New | +$240K | 0.01% | 730 |
|
|
2018
Q2 | – | Sell |
-25,193
| Closed | -$1.15M | – | 1618 |
|
|
2018
Q1 | $1.15M | Buy |
25,193
+5,681
| +29% | +$260K | 0.02% | 533 |
|
|
2017
Q4 | $778K | Sell |
19,512
-19,142
| -50% | -$763K | 0.01% | 624 |
|
|
2017
Q3 | $1.55M | Buy |
38,654
+4,012
| +12% | +$160K | 0.02% | 456 |
|
|
2017
Q2 | $1.49M | Sell |
34,642
-2,626
| -7% | -$113K | 0.02% | 571 |
|
|
2017
Q1 | $1.17M | Sell |
37,268
-11,920
| -24% | -$373K | 0.01% | 731 |
|
|
2016
Q4 | $1.24M | Buy |
+49,188
| New | +$1.24M | 0.01% | 667 |
|
|
2016
Q3 | – | Sell |
-14,948
| Closed | -$305K | – | 1620 |
|
|
2016
Q2 | $305K | Buy |
+14,948
| New | +$305K | ﹤0.01% | 1324 |
|
|
2016
Q1 | – | Sell |
-17,921
| Closed | -$241K | – | 1644 |
|
|
2015
Q4 | $241K | Buy |
+17,921
| New | +$241K | 0.01% | 1133 |
|
|
2014
Q4 | – | Sell |
-16,021
| Closed | -$139K | – | 1236 |
|
|
2014
Q3 | $139K | Buy |
+16,021
| New | +$139K | 0.01% | 800 |
|